Biotech & Pharma

Albumin-Fused Antibodies May Reduce Fetal Exposure to Therapeutics

26 sec read7 views0 listens

Researchers have discovered that fusing IgG antibodies with albumin can significantly reduce their transport across the placenta, minimizing fetal exposure during pregnancy. This breakthrough could lead to safer biologic medicines for treating chronic diseases in pregnant women by leveraging the placenta's ability to distinguish between these proteins. Further research is needed to optimize this approach and develop tailored therapeutics.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Cybersecurity15 hours ago27 sec read

The hidden economy beneath our feet: Plants share energy through fungal networks

New research provides experimental evidence that flowering plants can acquire carbon-based energy through underground fungal networks connecting to neighboring plants. This phenomenon, known as partial mycoheterotrophy, suggests a more interconnected...

Ali Nemati

Automotive & EV17 hours ago29 sec read

Hotel Brand Dilution: The Maddening But Predictable Trend Of Growth Over Quality

Hotel brands are becoming increasingly inconsistent as major groups prioritize growth over maintaining quality standards, leading to a decline in brand reliability. This shift matters because consumers can no longer trust a brand's reputation alone w...

Ali Nemati

Real Estate & Home2 days ago28 sec read

First-home buyer reveals Reddit hack that saved him from $30,000 mistake

An Australian first-time homebuyer in Brisbane used Reddit to navigate the property market successfully and avoid a costly mistake. By leveraging online communities, he gained valuable insights and support from experienced buyers, highlighting the gr...

Ali Nemati